New research uncovers how cancers with common mutation develop resistance to targeted drugs
More seniors may have undiagnosed dementia than previously thought
23 June 2021Pandemic drives largest decrease in US life expectancy since 1943
23 June 2021New research uncovers how cancers with common mutation develop resistance to targeted drugs
A new study by Dana-Farber Cancer Institute researchers has given scientists their first look at the genomic landscape of tumors that have grown resistant to drugs targeting the abnormal KRASG12C protein. Their work shows that, far from adopting a common route to becoming resistant, the cells take a strikingly diverse set of avenues, often several at a time.
